{
  "schema_version": "3.1.1-production",
  "doc_id": "CT-19803",
  "evaluation_id": "CT-19803",
  "extraction_date": "2022-04-20",
  "extraction_metadata": {
    "processing_version": "auto",
    "extraction_date": "2022-04-20",
    "parser": "auto",
    "annotateur_default": "auto",
    "niveau_confiance_default": 4,
    "source_files": {
      "F1": {
        "file_name": "ct_CT-19803_VAXELIS_PIS_INS_COMPLEMENT_GAMME_AvisDef_CT19803.pdf",
        "type": "CT",
        "page_count": 5
      }
    }
  },
  "template_detecte": "CT_modern",
  "section_taxonomy_version": "1.0",
  "SegmentIndex": [
    {
      "segment_id": "CT-19803_seg_01",
      "section_label_normalise": "SYNTHESE_DE_L_AVIS",
      "section_label_brut": "L’essentiel",
      "template_detecte": "CT_modern",
      "page_start": 1,
      "page_end": 1,
      "char_start": 0,
      "char_end": null,
      "heading_text": "L’essentiel",
      "expected_fields": [
        "synthèse_avis"
      ],
      "routing_hint": "Résumé de l'avis",
      "label_confidence": 0.95
    },
    {
      "segment_id": "CT-19803_seg_02",
      "section_label_normalise": "CONTEXTE_EVALUATION",
      "section_label_brut": "CONTEXTE",
      "template_detecte": "CT_modern",
      "page_start": 2,
      "page_end": 2,
      "char_start": null,
      "char_end": null,
      "heading_text": "CONTEXTE",
      "expected_fields": [
        "contexte_demande"
      ],
      "routing_hint": "Description de la demande",
      "label_confidence": 0.95
    },
    {
      "segment_id": "CT-19803_seg_03",
      "section_label_normalise": "INDICATIONS_THERAPEUTIQUES",
      "section_label_brut": "INDICATIONS",
      "template_detecte": "CT_modern",
      "page_start": 2,
      "page_end": 2,
      "char_start": null,
      "char_end": null,
      "heading_text": "INDICATIONS",
      "expected_fields": [
        "indication"
      ],
      "routing_hint": "Indications du vaccin",
      "label_confidence": 0.95
    },
    {
      "segment_id": "CT-19803_seg_04",
      "section_label_normalise": "COMPARATEURS_PERTINENTS",
      "section_label_brut": "COMPARATEURS CLINIQUEMENT PERTINENTS",
      "template_detecte": "CT_modern",
      "page_start": 2,
      "page_end": 3,
      "char_start": null,
      "char_end": null,
      "heading_text": "COMPARATEURS CLINIQUEMENT PERTINENTS",
      "expected_fields": [
        "comparateurs",
        "tableau_comparateurs"
      ],
      "routing_hint": "Comparateurs identifiés par la HAS",
      "label_confidence": 0.95
    },
    {
      "segment_id": "CT-19803_seg_05",
      "section_label_normalise": "SERVICE_MEDICAL_RENDU",
      "section_label_brut": "CONCLUSIONS DE LA COMMISSION",
      "template_detecte": "CT_modern",
      "page_start": 4,
      "page_end": 4,
      "char_start": null,
      "char_end": null,
      "heading_text": "CONCLUSIONS DE LA COMMISSION",
      "expected_fields": [
        "conclusions_smr",
        "conclusions_asmr"
      ],
      "routing_hint": "Conclusions sur le SMR et l'ASMR",
      "label_confidence": 0.95
    },
    {
      "segment_id": "CT-19803_seg_06",
      "section_label_normalise": "INFORMATIONS_ADMINISTRATIVES",
      "section_label_brut": "INFORMATIONS ADMINISTRATIVES ET REGLEMENTAIRES",
      "template_detecte": "CT_modern",
      "page_start": 5,
      "page_end": 5,
      "char_start": null,
      "char_end": null,
      "heading_text": "INFORMATIONS ADMINISTRATIVES ET REGLEMENTAIRES",
      "expected_fields": [
        "amm",
        "conditions_prescription",
        "code_atc"
      ],
      "routing_hint": "Informations administratives et réglementaires",
      "label_confidence": 0.95
    }
  ],
  "Identifiants_Produits_Liaison": [
    {
      "produit_id": "CT-19803_prod_VAXELIS",
      "evaluation_id": "CT-19803",
      "nom_commercial": "VAXELIS",
      "dci": "vaccin diphtérique, tétanique, coquelucheux (acellulaire, multicomposé), de l'hépatite B (ADNr), poliomyélitique (inactivé) et conjugué de l'Haemophilus de type b (adsorbé)",
      "cip13": "34009 300 797 8 2",
      "forme_pharmaceutique": "suspension injectable en seringue préremplie",
      "titulaire_amm": "MSD Vaccins",
      "code_atc": "J07CA09",
      "comparateur_hierarchie": null,
      "evidence": [
        {
          "field": "cip13",
          "f": "F1",
          "p": 5,
          "s": "INFORMA",
          "t": "CIP : 34009 300 797 8 2",
          "m": "manual",
          "c": 0.95
        }
      ]
    }
  ],
  "Evaluations_HAS": [
    {
      "evaluation_id": "CT-19803",
      "Num_avis": "CT-19803",
      "produit_nom": "VAXELIS",
      "dci": "vaccin diphtérique, tétanique, coquelucheux (acellulaire, multicomposé), de l'hépatite B (ADNr), poliomyélitique (inactivé) et conjugué de l'Haemophilus de type b (adsorbé)",
      "type_avis": "Inscription",
      "forme": "suspension injectable en seringue préremplie",
      "dosage": "0.5 ml",
      "indication": "chez les nourrissons à partir de l’âge de 6 semaines pour la primovaccination et la vaccination de rappel contre la diphtérie, le tétanos, la coqueluche, l'hépatite B, la poliomyélite et les maladies invasives à Haemophilus influenzae type b (Hib)",
      "classe_ATC": "J07CA09",
      "pathologie": "vaccin",
      "maladie_rare": false,
      "ligne_traitement": "Non renseigné",
      "sous_groupe_population": "nourrissons à partir de 6 semaines",
      "cim10_principal": "Non renseigné",
      "cim10_secondaires": [],
      "libelle_cim10": "Non renseigné",
      "source_cim10": "Non renseigné",
      "aire_therapeutique_niveau_1": "Anti-infectieux généraux à usage systémique",
      "aire_therapeutique_niveau_2": "Vaccins",
      "aire_therapeutique_niveau_3": "Vaccins bactériens et viraux associés",
      "source_aire_therapeutique": "Déduit ATC J07CA09",
      "design_etude": "Non renseigné",
      "niveau_preuve_brut": "Non renseigné",
      "niveau_preuve_interprete": "Non renseigné",
      "besoin_medical_brut": "Non renseigné",
      "besoin_medical_interprete": "Non renseigné",
      "pathologie_categorie_enum": "Infectiologie",
      "age_restriction_flag": true,
      "age_restriction_detail": "nourrissons à partir de 6 semaines",
      "biomarqueur_requis": "Non renseigné",
      "design_enum": "Non renseigné",
      "type_avis_enum": "Inscription",
      "caractere_innovant_reconnu": false,
      "perte_de_chance_citee": false,
      "historique_Has_produit": "Avis du 11 octobre 2017 (CT-16299) avec SMR important",
      "historique_ASMR_comparateurs": "Non renseigné",
      "concurrence_therapeutique_recente": "Non renseigné",
      "vote_unanimite": null,
      "nb_votants": null,
      "nb_voix_pour": null,
      "nb_voix_contre": null,
      "nb_abstentions": null,
      "date_evaluation": "2022-04-20",
      "transcription_textuelle": "Non renseigné",
      "extraits_arguments": [],
      "gravite_patho": "La diphtérie, le tétanos, la poliomyélite, la coqueluche, les infections à Haemophilus influenzae type b et l'hépatite B sont des infections graves, pouvant mettre en jeu le pronostic vital.",
      "gravite_patho_enum": [
        "Grave"
      ],
      "type_population_cible": "nourrissons à partir de 6 semaines",
      "pertinence_concurrence_therapeutique": "Les comparateurs cliniquement pertinents sont les deux présentations de VAXELIS déjà commercialisées, ainsi que les autres vaccins hexavalents INFANRIX HEXA et HEXYON.",
      "evidence": [
        {
          "field": "indication",
          "f": "F1",
          "p": 2,
          "s": "INDICATI",
          "t": "VAXELIS (D-T-Polio-Ca-Hib-HepB) est indiqué chez les nourrissons à partir de l’âge de 6 semaines pour la primovaccination et la vaccination de rappel contre la diphtérie, le tétanos, la coqueluche, l’hépatite B, la poliomyélite et les maladies invasives à Haemophilus influenzae type b (Hib).",
          "m": "manual",
          "c": 0.95
        },
        {
          "field": "date_evaluation",
          "f": "F1",
          "p": 5,
          "s": "Calendrie",
          "t": "Date d’examen et d’adoption : 20/04/2022",
          "m": "manual",
          "c": 0.95
        }
      ],
      "_meta": {}
    }
  ],
  "Essais_Cliniques": [
    {
      "essai_id": "CT-19803_essai_principal",
      "evaluation_id": "CT-19803",
      "nom_essai": "Étude principale (nom non spécifié)",
      "nct_number": "Non renseigné",
      "design": "Non renseigné",
      "population_cible": "nourrissons à partir de 6 semaines",
      "comparateur_utilise": "INFANRIX HEXA, HEXYON",
      "nb_patient_traitement": null,
      "nb_patient_comparateur": null,
      "resultat_global": "Le rapport immunogénicité/effets indésirables est important.",
      "QoL_flag": null,
      "niveau_preuve": "Non renseigné",
      "pooling_flag": null,
      "population_dedoublée": null,
      "suivi_median_mois": null,
      "arret_premature_flag": false,
      "duree_traitement_moyenne_mois": null,
      "phase": "Non renseigné",
      "aveugle": "Non renseigné",
      "randomisation_flag": null,
      "randomisation_ratio": "Non renseigné",
      "stratification_flag": null,
      "stratification_facteurs": [],
      "population_analyse_principale": "Non renseigné",
      "date_cutoff_donnees": "Non renseigné",
      "duree_suivi_prevu_mois": null,
      "maturite_donnees": "Non renseigné",
      "age_min_num": 0.14,
      "age_max_num": null,
      "ligne_traitement_essai_enum": "Non renseigné",
      "comparateur_type_enum": "Traitement_actif",
      "efficacite_demontree": null,
      "magnitude_effet_categorie": "Non renseigné",
      "maturite_pct": null,
      "arret_premature_raison": "Non applicable",
      "arret_premature_date": "Non renseigné",
      "analyse_interimaire_plannifiee": null,
      "qol_instruments": [],
      "qol_resultats_brut": "Non renseigné",
      "qol_difference_cliniquement_pertinente": null,
      "qol_favorable": null,
      "nb_facteurs_stratification": null,
      "nb_patients_inclus": "Non renseigné",
      "nb_patients_inclus_par_pays": [],
      "date_fin_inclusion": "Non renseigné",
      "nb_analyses_intermediaire": null,
      "date_analyses_intermediares_mois": [],
      "evidence": [
        {
          "field": "resultat_global",
          "f": "F1",
          "p": 4,
          "s": "Le rapport",
          "t": "Le rapport immunogénicité/effets indésirables est important.",
          "m": "manual",
          "c": 0.9
        }
      ],
      "_meta": {}
    },
    {
      "essai_id": "CT-19803_essai_PRI03C",
      "evaluation_id": "CT-19803",
      "nom_essai": "PRI03C",
      "nct_number": "Non renseigné",
      "design": "Non renseigné",
      "population_cible": "Non renseigné",
      "comparateur_utilise": "Non renseigné",
      "nb_patient_traitement": null,
      "nb_patient_comparateur": null,
      "resultat_global": "Non renseigné",
      "QoL_flag": null,
      "niveau_preuve": "Non renseigné",
      "pooling_flag": null,
      "population_dedoublée": null,
      "suivi_median_mois": null,
      "arret_premature_flag": false,
      "duree_traitement_moyenne_mois": null,
      "phase": "Non renseigné",
      "aveugle": "Non renseigné",
      "randomisation_flag": null,
      "randomisation_ratio": "Non renseigné",
      "stratification_flag": null,
      "stratification_facteurs": [],
      "population_analyse_principale": "Non renseigné",
      "date_cutoff_donnees": "Non renseigné",
      "duree_suivi_prevu_mois": null,
      "maturite_donnees": "Non renseigné",
      "age_min_num": null,
      "age_max_num": null,
      "ligne_traitement_essai_enum": "Non renseigné",
      "comparateur_type_enum": "Non renseigné",
      "efficacite_demontree": null,
      "magnitude_effet_categorie": "Non renseigné",
      "maturite_pct": null,
      "arret_premature_raison": "Non applicable",
      "arret_premature_date": "Non renseigné",
      "analyse_interimaire_plannifiee": null,
      "qol_instruments": [],
      "qol_resultats_brut": "Non renseigné",
      "qol_difference_cliniquement_pertinente": null,
      "qol_favorable": null,
      "nb_facteurs_stratification": null,
      "nb_patients_inclus": "Non renseigné",
      "nb_patients_inclus_par_pays": [],
      "date_fin_inclusion": "Non renseigné",
      "nb_analyses_intermediaire": null,
      "date_analyses_intermediares_mois": [],
      "evidence": [
        {
          "field": "nom_essai",
          "f": "F1",
          "p": 5,
          "s": "11/01/201",
          "t": "ajout des données de persistance à long de la réponse immunitaire coqueluche et hépatite B (étude PRI03C)",
          "m": "manual",
          "c": 0.9
        }
      ],
      "_meta": {}
    },
    {
      "essai_id": "CT-19803_essai_challenge_hepatite_B",
      "evaluation_id": "CT-19803",
      "nom_essai": "étude de challenge hépatite B",
      "nct_number": "Non renseigné",
      "design": "Non renseigné",
      "population_cible": "Non renseigné",
      "comparateur_utilise": "Non renseigné",
      "nb_patient_traitement": null,
      "nb_patient_comparateur": null,
      "resultat_global": "Non renseigné",
      "QoL_flag": null,
      "niveau_preuve": "Non renseigné",
      "pooling_flag": null,
      "population_dedoublée": null,
      "suivi_median_mois": null,
      "arret_premature_flag": false,
      "duree_traitement_moyenne_mois": null,
      "phase": "Non renseigné",
      "aveugle": "Non renseigné",
      "randomisation_flag": null,
      "randomisation_ratio": "Non renseigné",
      "stratification_flag": null,
      "stratification_facteurs": [],
      "population_analyse_principale": "Non renseigné",
      "date_cutoff_donnees": "Non renseigné",
      "duree_suivi_prevu_mois": null,
      "maturite_donnees": "Non renseigné",
      "age_min_num": null,
      "age_max_num": null,
      "ligne_traitement_essai_enum": "Non renseigné",
      "comparateur_type_enum": "Non renseigné",
      "efficacite_demontree": null,
      "magnitude_effet_categorie": "Non renseigné",
      "maturite_pct": null,
      "arret_premature_raison": "Non applicable",
      "arret_premature_date": "Non renseigné",
      "analyse_interimaire_plannifiee": null,
      "qol_instruments": [],
      "qol_resultats_brut": "Non renseigné",
      "qol_difference_cliniquement_pertinente": null,
      "qol_favorable": null,
      "nb_facteurs_stratification": null,
      "nb_patients_inclus": "Non renseigné",
      "nb_patients_inclus_par_pays": [],
      "date_fin_inclusion": "Non renseigné",
      "nb_analyses_intermediaire": null,
      "date_analyses_intermediares_mois": [],
      "evidence": [
        {
          "field": "nom_essai",
          "f": "F1",
          "p": 5,
          "s": "21/02/202",
          "t": "inclusion des données de l’étude de challenge hépatite B",
          "m": "manual",
          "c": 0.9
        }
      ],
      "_meta": {}
    }
  ],
  "Critères_Jugement": [
    {
      "critere_id": "CT-19803_essai_principal_crit_immunogenicite",
      "evaluation_id": "CT-19803",
      "essai_id": "CT-19803_essai_principal",
      "nom_critere": "immunogénicité",
      "nature_critere": "Substitutif",
      "unite_mesure": "Non renseigné",
      "hierarchie_critere": "Non renseigné",
      "ordre_hierarchie": null,
      "critere_co_primaire_groupe": null,
      "condition_test": null,
      "ajustement_alpha_realise": false,
      "methode_ajustement_alpha": "Non applicable",
      "alpha_ajuste": null,
      "alpha_global_famille": null,
      "nombre_tests_famille": null,
      "test_statistique_utilise": "Non renseigné",
      "modele_ajuste": null,
      "facteurs_ajustement": [],
      "analyse_stratifiee": null,
      "valeur_groupe_traitement": "Non renseigné",
      "valeur_groupe_comparateur": "Non renseigné",
      "gain_absolu": "Non renseigné",
      "gain_absolu_num": null,
      "gain_relatif": "Non renseigné",
      "gain_relatif_num": null,
      "HR_RR_OR": "Non renseigné",
      "HR_RR_OR_num": null,
      "IC95": "Non renseigné",
      "IC95_low_num": null,
      "IC95_high_num": null,
      "p_value": "Non renseigné",
      "p_value_num": null,
      "unite_normalisee": "Autre",
      "type_effet": "Autre",
      "significativite_statistique": false,
      "critere_atteint": false,
      "degre_signification": "Non_teste",
      "pertinence_clinique": "Non renseigné",
      "commentaire_has_resultat": "Non renseigné",
      "is_primary": false,
      "evidence": [],
      "_meta": {}
    },
    {
      "critere_id": "CT-19803_essai_principal_crit_effets_indesirables",
      "evaluation_id": "CT-19803",
      "essai_id": "CT-19803_essai_principal",
      "nom_critere": "effets indésirables",
      "nature_critere": "Substitutif",
      "unite_mesure": "Non renseigné",
      "hierarchie_critere": "Non renseigné",
      "ordre_hierarchie": null,
      "critere_co_primaire_groupe": null,
      "condition_test": null,
      "ajustement_alpha_realise": false,
      "methode_ajustement_alpha": "Non applicable",
      "alpha_ajuste": null,
      "alpha_global_famille": null,
      "nombre_tests_famille": null,
      "test_statistique_utilise": "Non renseigné",
      "modele_ajuste": null,
      "facteurs_ajustement": [],
      "analyse_stratifiee": null,
      "valeur_groupe_traitement": "Non renseigné",
      "valeur_groupe_comparateur": "Non renseigné",
      "gain_absolu": "Non renseigné",
      "gain_absolu_num": null,
      "gain_relatif": "Non renseigné",
      "gain_relatif_num": null,
      "HR_RR_OR": "Non renseigné",
      "HR_RR_OR_num": null,
      "IC95": "Non renseigné",
      "IC95_low_num": null,
      "IC95_high_num": null,
      "p_value": "Non renseigné",
      "p_value_num": null,
      "unite_normalisee": "Autre",
      "type_effet": "Autre",
      "significativite_statistique": false,
      "critere_atteint": false,
      "degre_signification": "Non_teste",
      "pertinence_clinique": "Non renseigné",
      "commentaire_has_resultat": "Non renseigné",
      "is_primary": false,
      "evidence": [],
      "_meta": {}
    },
    {
      "critere_id": "CT-19803_essai_PRI03C_crit_persistance_reponse_immunitaire",
      "evaluation_id": "CT-19803",
      "essai_id": "CT-19803_essai_PRI03C",
      "nom_critere": "persistance à long terme de la réponse immunitaire coqueluche et hépatite B",
      "nature_critere": "Substitutif",
      "unite_mesure": "Non renseigné",
      "hierarchie_critere": "Non renseigné",
      "ordre_hierarchie": null,
      "critere_co_primaire_groupe": null,
      "condition_test": null,
      "ajustement_alpha_realise": false,
      "methode_ajustement_alpha": "Non applicable",
      "alpha_ajuste": null,
      "alpha_global_famille": null,
      "nombre_tests_famille": null,
      "test_statistique_utilise": "Non renseigné",
      "modele_ajuste": null,
      "facteurs_ajustement": [],
      "analyse_stratifiee": null,
      "valeur_groupe_traitement": "Non renseigné",
      "valeur_groupe_comparateur": "Non renseigné",
      "gain_absolu": "Non renseigné",
      "gain_absolu_num": null,
      "gain_relatif": "Non renseigné",
      "gain_relatif_num": null,
      "HR_RR_OR": "Non renseigné",
      "HR_RR_OR_num": null,
      "IC95": "Non renseigné",
      "IC95_low_num": null,
      "IC95_high_num": null,
      "p_value": "Non renseigné",
      "p_value_num": null,
      "unite_normalisee": "Autre",
      "type_effet": "Autre",
      "significativite_statistique": false,
      "critere_atteint": false,
      "degre_signification": "Non_teste",
      "pertinence_clinique": "Non renseigné",
      "commentaire_has_resultat": "Non renseigné",
      "is_primary": false,
      "evidence": [],
      "_meta": {}
    },
    {
      "critere_id": "CT-19803_essai_challenge_hepatite_B_crit_reponse_challenge",
      "evaluation_id": "CT-19803",
      "essai_id": "CT-19803_essai_challenge_hepatite_B",
      "nom_critere": "réponse au challenge hépatite B",
      "nature_critere": "Substitutif",
      "unite_mesure": "Non renseigné",
      "hierarchie_critere": "Non renseigné",
      "ordre_hierarchie": null,
      "critere_co_primaire_groupe": null,
      "condition_test": null,
      "ajustement_alpha_realise": false,
      "methode_ajustement_alpha": "Non applicable",
      "alpha_ajuste": null,
      "alpha_global_famille": null,
      "nombre_tests_famille": null,
      "test_statistique_utilise": "Non renseigné",
      "modele_ajuste": null,
      "facteurs_ajustement": [],
      "analyse_stratifiee": null,
      "valeur_groupe_traitement": "Non renseigné",
      "valeur_groupe_comparateur": "Non renseigné",
      "gain_absolu": "Non renseigné",
      "gain_absolu_num": null,
      "gain_relatif": "Non renseigné",
      "gain_relatif_num": null,
      "HR_RR_OR": "Non renseigné",
      "HR_RR_OR_num": null,
      "IC95": "Non renseigné",
      "IC95_low_num": null,
      "IC95_high_num": null,
      "p_value": "Non renseigné",
      "p_value_num": null,
      "unite_normalisee": "Autre",
      "type_effet": "Autre",
      "significativite_statistique": false,
      "critere_atteint": false,
      "degre_signification": "Non_teste",
      "pertinence_clinique": "Non renseigné",
      "commentaire_has_resultat": "Non renseigné",
      "is_primary": false,
      "evidence": [],
      "_meta": {}
    }
  ],
  "Tolérance": [
    {
      "tolerance_id": "CT-19803_essai_principal_tol",
      "evaluation_id": "CT-19803",
      "essai_id": "CT-19803_essai_principal",
      "ae_total_pct": null,
      "ae_total_pct_comparateur": null,
      "sae_pct": null,
      "sae_pct_comparateur": null,
      "discontinuations_ae_pct": null,
      "discontinuations_ae_pct_comparateur": null,
      "deaths_ae_n": null,
      "deaths_ae_n_comparateur": null,
      "sae_data_available": false,
      "sae_superieur_comparateur": null,
      "deaths_reported": false,
      "EI_graves_detailles": [],
      "EI_frequents_detailles": [],
      "ei_grade_max": "Non renseigné",
      "deces_detailles": [],
      "signal_securite_flag": false,
      "signal_securite_detailles": [],
      "signal_ansm_flag": false,
      "EI_graves": "Non renseigné",
      "EI_frequents": "Non renseigné",
      "deces": "Non renseigné",
      "signal_securite": "Non renseigné",
      "evidence": [],
      "_meta": {}
    }
  ],
  "Comparateurs_Essai": [
    {
      "comparateur_id": "CT-19803_essai_principal_comp_01",
      "essai_id": "CT-19803_essai_principal",
      "nom_comparateur": "INFANRIX HEXA",
      "type_comparateur": "Traitement_actif",
      "comparateur_standard_soin": "Oui",
      "comparateur_standard_enum": "Vaccin",
      "evidence": [
        {
          "field": "nom_comparateur",
          "f": "F1",
          "p": 3,
          "s": "Tableau 1",
          "t": "INFANRIX HEXA",
          "m": "manual",
          "c": 0.95
        }
      ],
      "_meta": {}
    },
    {
      "comparateur_id": "CT-19803_essai_principal_comp_02",
      "essai_id": "CT-19803_essai_principal",
      "nom_comparateur": "HEXYON",
      "type_comparateur": "Traitement_actif",
      "comparateur_standard_soin": "Oui",
      "comparateur_standard_enum": "Vaccin",
      "evidence": [
        {
          "field": "nom_comparateur",
          "f": "F1",
          "p": 3,
          "s": "Tableau 1",
          "t": "HEXYON",
          "m": "manual",
          "c": 0.95
        }
      ],
      "_meta": {}
    }
  ],
  "Comparateurs_HAS": [
    {
      "comparateur_id": "CT-19803_compHAS_01",
      "evaluation_id": "CT-19803",
      "nom_comparateur_HAS": "INFANRIX HEXA",
      "type_comparateur": "Traitement_actif",
      "comparateur_standard_soin": "Oui",
      "famille_comparateur": "Vaccin",
      "evidence": [
        {
          "field": "nom_comparateur_HAS",
          "f": "F1",
          "p": 3,
          "s": "Tableau 1",
          "t": "INFANRIX HEXA",
          "m": "manual",
          "c": 0.95
        }
      ],
      "_meta": {}
    },
    {
      "comparateur_id": "CT-19803_compHAS_02",
      "evaluation_id": "CT-19803",
      "nom_comparateur_HAS": "HEXYON",
      "type_comparateur": "Traitement_actif",
      "comparateur_standard_soin": "Oui",
      "famille_comparateur": "Vaccin",
      "evidence": [
        {
          "field": "nom_comparateur_HAS",
          "f": "F1",
          "p": 3,
          "s": "Tableau 1",
          "t": "HEXYON",
          "m": "manual",
          "c": 0.95
        }
      ],
      "_meta": {}
    }
  ],
  "Arguments_Decisionnels": [],
  "Données_Contexte": {
    "contexte_id": "CT-19803_ctx",
    "evaluation_id": "CT-19803",
    "ISP": "Non renseigné",
    "acces_precoce": "Aucun",
    "date_debut_acces_precoce": "Non renseigné",
    "date_fin_acces_precoce": "Non renseigné",
    "duree_acces_precoce_mois": null,
    "nombre_patients_acces_precoce": null,
    "conditions_arret_acces_precoce": "Non renseigné",
    "ISP_flag": false,
    "ISP_categorie": "Pas_ISP",
    "type_acces_precoce_enum": "Aucun",
    "statut_reglementaire_ema": "AMM_standard",
    "date_AMM_ema": "2016-02-15",
    "date_avis_chmp": "Non renseigné",
    "innovation_therapeutique_ema": false,
    "designation_orpheline_ema": false,
    "prime_ema": false,
    "obligations_post_amm": [],
    "echeance_reexamen_amm": "Non renseigné",
    "nb_obligations_post_amm": null,
    "evaluation_internationale": "Non renseigné",
    "pays_evaluations": [],
    "decisions_internationales": [],
    "nb_decisions_internationales": null,
    "RDCR": "Non renseigné",
    "RDCR_num": null,
    "RDCR_intervalle": null,
    "RDCR_vs_seuil": "Non_applicable",
    "model_type": "Non renseigné",
    "perspective": "Non renseigné",
    "horizon_annees": null,
    "horizon_justification": "Non renseigné",
    "discount_rate_costs": null,
    "discount_rate_qalys": null,
    "DSA_flag": null,
    "PSA_flag": null,
    "scenario_analyses": [],
    "major_reserves": [],
    "nb_reserves_majeures": null,
    "impact_budgetaire_prevu": "Non renseigné",
    "impact_budgetaire_annee_1": null,
    "impact_budgetaire_annee_5": null,
    "impact_budgetaire_horizon": null,
    "hypothese_population_cible": null,
    "hypothese_penetration_marche_pct": null,
    "reserves_impact_budgetaire": [],
    "reserves_majeures": false,
    "population_cible_france": "Non renseigné",
    "population_cible_nombre": null,
    "population_cible_intervalle": null,
    "source_estimation_population": "Non renseigné",
    "incertitude_population": "Non renseigné",
    "population_cible_mediane": null,
    "suivi_post_inscription": false,
    "nature_suivi_post_inscription": "Non renseigné",
    "delai_suivi_mois": null,
    "delai_suivi_justification": "Non renseigné",
    "conditions_suivi": "Non renseigné",
    "echeance_suivi": "Non renseigné",
    "impact_si_non_realise": "Non précisé",
    "delai_soumission_dossier": "Non renseigné",
    "delai_complement_demande": false,
    "dates_complement_demande": [],
    "delai_audition": false,
    "date_audition": "Non renseigné",
    "nb_total_reserves": null,
    "nb_total_reserves_mineures": null,
    "nb_totales_reserves_importantes": null,
    "nb_totales_reserves_majeures": null,
    "SMR_avant_audition_enum": "Non_renseigné",
    "SMR_apres_audition_enum": "Non_renseigné",
    "ASMR_avant_audition_enum": "Non_renseigné",
    "ASMR_après_audition_enum": "Non_renseigné",
    "type_critère_justification": "Non renseigné",
    "valeur_critère": "Non renseigné",
    "impact_décision": "Non renseigné",
    "estimation_mesure_impact": "Non renseigné",
    "evidence": [
      {
        "field": "date_AMM_ema",
        "f": "F1",
        "p": 5,
        "s": "AMM Date",
        "t": "Date initiale (procédure centralisée) : 15/02/2016",
        "m": "manual",
        "c": 0.95
      }
    ],
    "_meta": {}
  },
  "Données_Textuelles": {
    "evaluation_id": "CT-19803",
    "texte_brut": "Non renseigné",
    "embedding": null,
    "evidence": []
  },
  "SMR_ASMR_Par_Indication": [
    {
      "smr_asmr_id": "CT-19803_smrasmr_01",
      "evaluation_id": "CT-19803",
      "indication_precise": "chez les nourrissons à partir de l’âge de 6 semaines pour la primovaccination et la vaccination de rappel contre la diphtérie, le tétanos, la coqueluche, l'hépatite B, la poliomyélite et les maladies invasives à Haemophilus influenzae type b (Hib)",
      "smr": "La Commission considère que le service médical rendu par VAXELIS (D-T-Polio-Ca-Hib-HepB), suspension injectable en seringue préremplie, en boîte de 1 seringue préremplie (verre) + 1 aiguille est IMPORTANT dans l’indication de l’AMM et pour les populations recommandées.",
      "asmr": "VAXELIS (D-T-Polio-Ca-Hib-HepB), suspension injectable en seringue préremplie, en boîte de 1 seringue préremplie (verre) + 1 aiguille est un complément de gamme qui n’apporte pas d’amélioration du service médical rendu (ASMR V) par rapport aux présentations déjà inscrites.",
      "smr_revendique": "Non renseigné",
      "asmr_revendique": "Non renseigné",
      "justification_decisionnelle": "La Commission donne un avis favorable à l'inscription sur la liste des spécialités remboursables aux assurés sociaux et sur la liste des spécialités agréées à l’usage des collectivités dans l’indication et pour les populations recommandées. Taux de remboursement proposé : 65%.",
      "population_cible_indication": "nourrissons à partir de 6 semaines",
      "ligne_traitement_indication": "Non renseigné",
      "comparateurs_references_indication": "INFANRIX HEXA, HEXYON",
      "comparateur_id_HAS": [
        "CT-19803_compHAS_01",
        "CT-19803_compHAS_02"
      ],
      "indication_structuree": {
        "ligne_traitement": "Non renseigné",
        "biomarqueur": "Aucun",
        "stade": "Non renseigné",
        "population_age": "nourrissons à partir de 6 semaines"
      },
      "gain_survie_cite": false,
      "qol_cite": false,
      "tolerance_acceptable": null,
      "evidence_robustesse": "Non renseigné",
      "asmr_revendique_enum": "Non_renseigné",
      "evidence": [
        {
          "field": "smr",
          "f": "F1",
          "p": 4,
          "s": "La Commis",
          "t": "La Commission considère que le service médical rendu par VAXELIS (D-T-Polio-Ca-Hib-HepB), suspension injectable en seringue préremplie, en boîte de 1 seringue préremplie (verre) + 1 aiguille est IMPORTANT dans l’indication de l’AMM et pour les populations recommandées.",
          "m": "manual",
          "c": 0.95
        },
        {
          "field": "asmr",
          "f": "F1",
          "p": 4,
          "s": "VAXELIS (",
          "t": "VAXELIS (D-T-Polio-Ca-Hib-HepB), suspension injectable en seringue préremplie, en boîte de 1 seringue préremplie (verre) + 1 aiguille est un complément de gamme qui n’apporte pas d’amélioration du service médical rendu (ASMR V) par rapport aux présentations déjà inscrites.",
          "m": "manual",
          "c": 0.95
        }
      ],
      "_meta": {}
    }
  ],
  "Posologie_Par_Indication": [],
  "Timeline_Evenements": [
    {
      "event_id": "CT-19803_event_AMM_01",
      "evaluation_id": "CT-19803",
      "event_type": "AMM_EMA_DECISION",
      "event_date": "2016-02-15",
      "detail_brut": "Date initiale (procédure centralisée) : 15/02/2016",
      "source_doc": "F1 page 5",
      "detail_type_specifique": "AMM initiale",
      "acteurs_impliques": [],
      "duree_evenement_jours": null,
      "reference_externe": "Non renseigné",
      "evidence": [
        {
          "field": "event_date",
          "f": "F1",
          "p": 5,
          "s": "AMM Date",
          "t": "Date initiale (procédure centralisée) : 15/02/2016",
          "m": "manual",
          "c": 0.95
        }
      ],
      "_meta": {}
    },
    {
      "event_id": "CT-19803_event_CT_01",
      "evaluation_id": "CT-19803",
      "event_type": "ADOPTION_CT",
      "event_date": "2022-04-20",
      "detail_brut": "Date d’examen et d’adoption : 20/04/2022",
      "source_doc": "F1 page 5",
      "detail_type_specifique": "Avis de la Commission de la Transparence",
      "acteurs_impliques": [],
      "duree_evenement_jours": null,
      "reference_externe": "Non renseigné",
      "evidence": [
        {
          "field": "event_date",
          "f": "F1",
          "p": 5,
          "s": "Calendrie",
          "t": "Date d’examen et d’adoption : 20/04/2022",
          "m": "manual",
          "c": 0.95
        }
      ],
      "_meta": {}
    }
  ],
  "Timeline_Delais": {
    "evaluation_id": "CT-19803",
    "delai_amm_ct_jours": 2253,
    "delai_transcription_ct_jours": null,
    "delai_audition_ct_jours": null,
    "complement_demande_mentionne": false,
    "audition_realisee": false,
    "evidence": [],
    "_meta": {}
  },
  "Features_Modele": {
    "evaluation_id": "CT-19803",
    "is_orphan": false,
    "classe_ATC_l2": "J07",
    "aire_therapeutique": "Vaccins",
    "type_avis_enum": "Inscription",
    "innovation_reconnue": false,
    "perte_de_chance_citee": false,
    "ligne_traitement_num": null,
    "is_rct": null,
    "n_essais": 3,
    "n_rct": 0,
    "presence_qol": false,
    "effet_principal_magnitude_num": null,
    "critere_principal_dur": false,
    "suivi_median_mois_max": null,
    "sae_pct_num": null,
    "discontinuations_pct_num": null,
    "critere_principal_description": "Non renseigné",
    "p_value_log10": null,
    "ceesp_present": false,
    "rdcr_num": null,
    "rdcr_log": null,
    "impact_budget_cat": "Non renseigné",
    "reserves_majeures": false,
    "nb_reserves_majeures": null,
    "vote_unanimite": null,
    "nb_votants": null,
    "voix_pour_pct": null,
    "association_patient_intervenue": false,
    "comparateur_placebo": false,
    "comparateur_soc": true,
    "nb_clockstops": 0,
    "annee_ct": 2022,
    "trimestre_ct": 2,
    "template_ere": "CT_modern",
    "missingness_indicators": {},
    "_meta": {}
  },
  "Relations": [
    {
      "src_type": "EVAL",
      "src_id": "CT-19803",
      "tgt_type": "TRIAL",
      "tgt_id": "CT-19803_essai_principal",
      "label": "EVAL_HAS_TRIAL"
    },
    {
      "src_type": "TRIAL",
      "src_id": "CT-19803_essai_principal",
      "tgt_type": "CRIT",
      "tgt_id": "CT-19803_essai_principal_crit_immunogenicite",
      "label": "TRIAL_HAS_CRIT"
    },
    {
      "src_type": "TRIAL",
      "src_id": "CT-19803_essai_principal",
      "tgt_type": "CRIT",
      "tgt_id": "CT-19803_essai_principal_crit_effets_indesirables",
      "label": "TRIAL_HAS_CRIT"
    },
    {
      "src_type": "TRIAL",
      "src_id": "CT-19803_essai_principal",
      "tgt_type": "TOL",
      "tgt_id": "CT-19803_essai_principal_tol",
      "label": "TRIAL_HAS_TOL"
    },
    {
      "src_type": "TRIAL",
      "src_id": "CT-19803_essai_principal",
      "tgt_type": "COMP",
      "tgt_id": "CT-19803_essai_principal_comp_01",
      "label": "TRIAL_HAS_COMPARATOR"
    },
    {
      "src_type": "TRIAL",
      "src_id": "CT-19803_essai_principal",
      "tgt_type": "COMP",
      "tgt_id": "CT-19803_essai_principal_comp_02",
      "label": "TRIAL_HAS_COMPARATOR"
    },
    {
      "src_type": "EVAL",
      "src_id": "CT-19803",
      "tgt_type": "COMP",
      "tgt_id": "CT-19803_compHAS_01",
      "label": "EVAL_HAS_COMP"
    },
    {
      "src_type": "EVAL",
      "src_id": "CT-19803",
      "tgt_type": "COMP",
      "tgt_id": "CT-19803_compHAS_02",
      "label": "EVAL_HAS_COMP"
    }
  ],
  "Annotation_View": []
}